Exagen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Exagen using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.28 | $-0.29 | 3.45 % |
Jun 2024 | 2024-08-05 | $-0.16 | $-0.35 | 54.3 % |
Mar 2024 | 2024-05-13 | $-0.19 | $-0.36 | 47.2 % |
Dec 2023 | 2024-03-18 | $-0.31 | $-0.43 | 27.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $12.51M | $13.56M | -7.77 % |
Jun 2024 | 2024-08-05 | $15.06M | $13.13M | 14.7 % |
Mar 2024 | 2024-05-13 | $14.42M | $13.09M | 10.1 % |
Dec 2023 | 2024-03-18 | $13.77M | $11.56M | 19.1 % |
Exagen ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3.
Exagen ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was $-0.28, which beat the estimate of $-0.29.
Exagen ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.